Breast cancer in women under 40years of age: A series of 57 cases from Northern Ireland

Breast

Volumn 19, Issue 2, 2010, Pages 97-104

  McAree, B ^a   O'Donnell, M E ^a,b   Spence, A ^a   Lioe, T F ^a   McManus, D T ^a   Spence, R A J ^a,b,c  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Breast; Cancer; Diagnosis; Genetics; Outcomes; Surgery; Young

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; EXEMESTANE; FLUOROURACIL; TAMOXIFEN; TRASTUZUMAB;

ADULT; ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOGRAPHY; FEMALE; HUMAN; IRELAND; LIVER METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PLASTIC SURGERY; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 77951208428     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2009.12.002     Document Type: Article

References (46)

1. NHS breast screening programmes Breast cancer paragraph 1.2 (last accessed 05/06/2009). http://www.cancerscreening.nhs.uk/breastscreen/breastcancer.html%23incidence.
2. Fitzpatrick D., Gavin A., Middleton R., Catney D. Cancer in Northern Ireland 1993-2001 2004, Northern Ireland Cancer Registry, Belfast, a comprehensive report.
3. Castiglione M., Aebi S. The enigma of young age. Ann Oncol 2006, 17(10):1475-1477.
4. Nixon A.J., Neuberg D., Hayes D.F., Gelman R., Connolly J.L., Schnitt S., et al. Relationship of patient age to pathological features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994, 12(5):888-894.
5. Dubsky P.C., Gnant M.F., Taucher S., Roka S., Kandioler D., Pichler-Gebhard B., et al. Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer. Clin Breast Cancer 2002, 3(1):65-72.
6. Aebi S., De Ridder M., Vlastos G., Vinh-Hung V., Storme G. Young age is a poor prognostic factor in women with stage I breast cancer. Eur J Cancer Suppl 2006, 4(2):121.
7. Bonnier P., Romain S., Charpin C., Lejeune C., Tubiana N., Martin P., et al. Age as a prognostic factor in breast cancer: relationship to pathological and biologic features. Int J Cancer 2006, 62(2):138-144.
8. Chung M., Chang H.R., Bland K.I., Wanebo H.J. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 1996, 77(1):97-103.
9. NICE clinical guideline 41 ; Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care; paragraph 1.4.5 Referral to tertiary care (accessed 01/05/2009). http://www.nice.org.uk.
10. McCavert M., O'Donnell M.E., Aroori S., Badger S.A., Sharif M.A., Crothers J.G., et al. The role of ultrasound as an adjunct to mammography in the assessment of breast tumours. Int J Clin Practice 2009, 63(11):1589-1594.
11. Non-operative Diagnosis Subgroup of the National Coordinating Group for Breast Screening Pathology. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening Publication No 50. National Health Service Breast Screening Programme NHSBSP 2001.
12. NHSBSP guidelines for pathology reporting in breast disease (a joint document incorporating the 3rd edition of the NHS Breast Screening Programme's guidelines for pathology reporting in breast cancer screening and the 2nd edition of The Royal College of Pathologists minimum dataset for breast cancer histopathology). NHSBSP publication No.58. London, England: National Health Service Breast Screening Programme, 2005.
13. Galea M.H., Blamey R.W., Elston C.E., Ellis I.O. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 1992, 22(3):207-219.
14. Improving outcomes in breast cancer - 28 Urgent referral to breast clinics; page 20; paragraph 2 (accessed 05/06/2009). http://www.nice.org.uk/nicemedia/pdf/improving_outcomes_breastcancer_manual.pdf.
15. Foxcroft L.M., Evans E.B., Porter A.J. The diagnosis of breast cancer in women younger than 40. Breast 2004, 13(4):297-306.
16. Pathology reporting of breast disease. A joint document incorporating the third edition of the NHS Breast Screening Programme's guidelines for pathology reporting in breast cancer screening and the second edition of The Royal College of Pathologists' minimum dataset for breast cancer histopathology. NHSBSP publication no. 58 January 2005. Published by the NHS Cancer Screening Programmes jointly with The Royal College of Pathologists.
17. Park C.C., Mitsumori M., Nixon A., Recht A., Connolly J., Gelman R., et al. Outcome at 8years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000, 18:1668-1675.
18. Irvin W.J., Carey L.A. What is triple-negative breast cancer?. Eur J Cancer 2008, 44(18):2799-2805.
19. Cancer research UK UK breast cancer incidence statistics; page 1; table 1.1 (accessed 05/06/2009). http://www.info.cancerresearchuk.org/cancerstats/types/breast/incidence/.
20. Winchester D.P. Breast cancer in young women. Surg Clin North Am 1996, 76(2):279-287.
21. Northern Ireland Cancer Registry Chapter 13 Cancer of the female breast ICD-9 174 (accessed 05/06/2009). http://www.qub.ac.uk/research-centres/nicr/Data/OnlineStatistics/Breast/.
22. Northern Ireland Cancer Registry a comprehensive report. Cancer in Northern Ireland 1993-2001, Queen's University of Belfast, (Comprehensive) (accessed 05/06/2009). http://www.qub.ac.uk/research-centres/nicr/Data/OnlineStatistics/Breast/.
23. NHS Cancer Screening Programmes NHS breast screening programme; paragraph 2: What does the NHS breast screening programme do? page 1; paragraph 2 (accessed 04/06/2009). http://www.cancerscreening.nhs.uk/breastscreen/.
24. Agnese D.M., Yusuf F., Wilson J.L., Shapiro C.L., Lehman A., Burak W.E. Trends in breast cancer presentation and care according to age in a single institution. Am J Surg 2004, 188(4):437-439.
25. Turchetti D., Cortesi L., Federico M., Bertoni C., Mangone L., Ferrari S., et al. BRCA1 mutations and clinicopathological features in a sample of Italian women with early-onset breast cancer. Eur J Cancer 2000, 36(16):2083-2089.
26. Peto J., Collins N., Barfoot R., Seal S., Warren W., Rahman N., et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 1999, 91(11):943-949.
27. Robson M., Gilewski T., Haas B., Levin D., Borgen P., Rajan P., et al. BRCA-associated breast cancer in young women. J Clin Oncol 1998, 16(5):1642-1649.
28. Radford D.M., Zehnbauer B.A. Inherited breast cancer. Surg Clin North Am 1996, 76(2):205-220.
29. Fernandopulle S.M., Cher-Siangang P., Tan P.H. Breast carcinoma in women 35years and younger: a pathological study. Pathology 2006, 38(3):219-222.
30. Colleoni M., Rotmensz N., Robertson C., Orlando L., Viale G., Renne G., et al. Very young women (<35years) with operable breast cancer: features of disease at presentation. Ann Oncol 2002, 13(2):273-279.
31. Anders C.K., Hsu D.S., Broadwater G., Acharya C.R., Foekens J.A., Zhang Y., et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 2008, 26(20):3324-3330.
32. Rosen P.P., Lesser M.L., Kinne D.W., Beattie E.J. Breast carcinoma in women 35years of age or younger. Ann Surg 1984, 199(2):133-142.
33. Albain K.S., Allred D.C., Clark G.M. Breast cancer outcome and predictors of outcome: are there age differentials?. J Natl Cancer Inst Monogr 1994, 16:35-42.
34. Bonnier P., Romain S., Charpin C., Lejeune C., Tubiana N., Martin P.M., et al. Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 1995, 62(2):138-144.
35. Vrieling C., Collette L., Fourquet A., Hoogenraad W.J., Horiot J.C., Jager J.J., et al. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?. Eur J Cancer 2003, 39(7):932-944.
36. Thike A.A., Chng M.J., Fook-Chong S., Tan P.H. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters. Pathology 2001, 33(1):21-25.
37. Northern Ireland Department of Health, Social Services and Public Safety news release. Herceptin (accessed 05/06/2009). http://www.dhsspsni.gov.uk/publications/2005/Herceptin.
38. Van Nes J.G., van de Velde C.J. The preferred treatment for young women with breast cancer - mastectomy versus breast conservation. Breast 2006, 15(Suppl.2):S3-10.
39. Zhou P., Gautam S., Recht A. Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat 2007, 101(1):51-57.
40. Dillon M.F., Hill A.D., Quinn C.M., McDermott E.W., O'Higgins N. A pathologic assessment of adequate margin status in breast-conserving therapy. Ann Surg Oncol 2006, 13(3):333-339.
41. Jardines L., Fowble B., Schultz D., Mackie J., Buzby G., Torosian M., et al. Factors associated with a positive reexcision after excisional biopsy for invasive breast cancer. Surgery 1995, 118:803-809.
42. Taghian A., Mohiuddin M., Jagsi R., Golberg S., Ceilley E., Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 2005, 241:629-639.
43. van der Hage J.A., van de Velde C.J., Julien J.P., Tubiana-Hulin M., Vandervelden C., Duchateau L. Pre-operative chemotherapy in primary operable breast cancer: results from the European Organisation for Research and Treatment of Cancer Trial 10902. J Clin Oncol 2001, 19:4224-4237.
44. Ingram D.M., McEvoy S.P., Byrne M.J., Fritschi L., Joseph D.J., Jamrozik K. Surgical caseload and outcomes for women with invasive breast cancer treated in Western Australia. Breast 2005, 14(1):11-17.
45. Bijker N., Peterse J.L., Duchateau L., Julien J.P., Fentiman I.S., Duval C., et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001, 19(8):2263-2271.
46. Goldstein N.S., Vicini F.A., Kestin L.L., Thomas M. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age. Cancer 2000, 88(11):2553-2560.